Recent Achievements in the Development of Biomaterials Improved with Platelet Concentrates for Soft and Hard Tissue Engineering Applications
Platelet concentrates such as platelet-rich plasma, platelet-rich fibrin or concentrated growth factors are cost-effective autologous preparations containing various growth factors, including platelet-derived growth factor, transforming growth factor β, insulin-like growth factor 1 and vascular endothelial growth factor. For this reason, they are often used in regenerative medicine to treat wounds, nerve damage as well as cartilage and bone defects. Unfortunately, after administration, these preparations release growth factors very quickly, which lose their activity rapidly. As a consequence, this results in the need to repeat the therapy, which is associated with additional pain and discomfort for the patient. Recent research shows that combining platelet concentrates with biomaterials overcomes this problem because growth factors are released in a more sustainable manner. Moreover, this concept fits into the latest trends in tissue engineering, which include biomaterials, bioactive factors and cells. Therefore, this review presents the latest literature reports on the properties of biomaterials enriched with platelet concentrates for applications in skin, nerve, cartilage and bone tissue engineering.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
International journal of molecular sciences - 25(2024), 3 vom: 26. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Grzelak, Agnieszka [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms25031525 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368283003 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368283003 | ||
003 | DE-627 | ||
005 | 20240214233323.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240210s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms25031525 |2 doi | |
028 | 5 | 2 | |a pubmed24n1293.xml |
035 | |a (DE-627)NLM368283003 | ||
035 | |a (NLM)38338805 | ||
035 | |a (PII)1525 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Grzelak, Agnieszka |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recent Achievements in the Development of Biomaterials Improved with Platelet Concentrates for Soft and Hard Tissue Engineering Applications |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2024 | ||
500 | |a Date Revised 14.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Platelet concentrates such as platelet-rich plasma, platelet-rich fibrin or concentrated growth factors are cost-effective autologous preparations containing various growth factors, including platelet-derived growth factor, transforming growth factor β, insulin-like growth factor 1 and vascular endothelial growth factor. For this reason, they are often used in regenerative medicine to treat wounds, nerve damage as well as cartilage and bone defects. Unfortunately, after administration, these preparations release growth factors very quickly, which lose their activity rapidly. As a consequence, this results in the need to repeat the therapy, which is associated with additional pain and discomfort for the patient. Recent research shows that combining platelet concentrates with biomaterials overcomes this problem because growth factors are released in a more sustainable manner. Moreover, this concept fits into the latest trends in tissue engineering, which include biomaterials, bioactive factors and cells. Therefore, this review presents the latest literature reports on the properties of biomaterials enriched with platelet concentrates for applications in skin, nerve, cartilage and bone tissue engineering | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a bone | |
650 | 4 | |a cartilage | |
650 | 4 | |a concentrated growth factors | |
650 | 4 | |a nerve | |
650 | 4 | |a platelet lysate | |
650 | 4 | |a platelet-rich fibrin | |
650 | 4 | |a platelet-rich plasma | |
650 | 4 | |a regenerative medicine | |
650 | 4 | |a scaffold | |
650 | 4 | |a skin | |
650 | 7 | |a Biocompatible Materials |2 NLM | |
650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
650 | 7 | |a Platelet-Derived Growth Factor |2 NLM | |
650 | 7 | |a Intercellular Signaling Peptides and Proteins |2 NLM | |
700 | 1 | |a Hnydka, Aleksandra |e verfasserin |4 aut | |
700 | 1 | |a Higuchi, Julia |e verfasserin |4 aut | |
700 | 1 | |a Michalak, Agnieszka |e verfasserin |4 aut | |
700 | 1 | |a Tarczynska, Marta |e verfasserin |4 aut | |
700 | 1 | |a Gaweda, Krzysztof |e verfasserin |4 aut | |
700 | 1 | |a Klimek, Katarzyna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 25(2024), 3 vom: 26. Jan. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:3 |g day:26 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms25031525 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 3 |b 26 |c 01 |